Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study

NCT02269969 is registered in ClinicalTrials.gov with Sandra Walker as lead sponsor.

NCT NCT02269969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02269969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study
Lead sponsor
Sandra Walker
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2015
Completion date
December 31, 2015
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns, infection